Home Newsfeeds PepGen Q2 EPS $(1.23)

PepGen Q2 EPS $(1.23)

PepGen (NASDAQ:PEPG) reported quarterly losses of $(1.23) per share.

byBill Haddad

August 12, 2022

1 minute read

PepGen (NASDAQ:PEPG) reported quarterly losses of $(1.23) per share.

ON Semiconductor Stock Jumps After Q2 Earnings – Here’s How It Performed

By Anusuya Lahiri

July 31, 9:35 AM

ON Semiconductor Corp (NASDAQ: ON) stock gained Monday after it reported flat second-quarter FY23 revenue growth year-on-year at $2.09 billion, beating the

News

Sunrise New Energy Co., Ltd. Highlights Its Position As A Benchmark In Technological Innovation, Product Quality And Management Efficiency In The Industry

By Benzinga Newsdesk

December 20, 11:21 AM

National Battery Industry Standard Policy titled "Technical Specifications for Artificial Graphite Anode Materials"ZIBO, China, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. ("Sunrise", the "Company",

EPOW

Newtek Business Services Forecasts Q4 2022 Distribution Of $0.70 Per Share, Up From $0.65

By Benzinga Newsdesk

September 28, 10:38 AM

BOCA RATON, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Newtek Business Services Corp., (NASDAQ:NEWT), an internally managed business development company ("BDC"), announced today it is forecasting

NEWT

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

By Lisa Levin

November 28, 7:39 AM

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AIM

PepGen Q2 EPS $(1.23)

Related Posts

ON Semiconductor Stock Jumps After Q2 Earnings – Here’s How It Performed

Sunrise New Energy Co., Ltd. Highlights Its Position As A Benchmark In Technological Innovation, Product Quality And Management Efficiency In The Industry

Newtek Business Services Forecasts Q4 2022 Distribution Of $0.70 Per Share, Up From $0.65

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying